310 related articles for article (PubMed ID: 30232520)
1. Sustained efficacy of adjuvant immunotherapy with cytokine-induced killer cells for hepatocellular carcinoma: an extended 5-year follow-up.
Lee JH; Lee JH; Lim YS; Yeon JE; Song TJ; Yu SJ; Gwak GY; Kim KM; Kim YJ; Lee JW; Yoon JH
Cancer Immunol Immunother; 2019 Jan; 68(1):23-32. PubMed ID: 30232520
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant immunotherapy with autologous cytokine-induced killer cells for hepatocellular carcinoma.
Lee JH; Lee JH; Lim YS; Yeon JE; Song TJ; Yu SJ; Gwak GY; Kim KM; Kim YJ; Lee JW; Yoon JH
Gastroenterology; 2015 Jun; 148(7):1383-91.e6. PubMed ID: 25747273
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant cytokine-induced killer cell immunotherapy for hepatocellular carcinoma: a propensity score-matched analysis of real-world data.
Yoon JS; Song BG; Lee JH; Lee HY; Kim SW; Chang Y; Lee YB; Cho EJ; Yu SJ; Sinn DH; Kim YJ; Lee JH; Yoon JH
BMC Cancer; 2019 May; 19(1):523. PubMed ID: 31151419
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of cytokine-induced killer cell infusion as an adjuvant immunotherapy for hepatocellular carcinoma: a systematic review and meta-analysis.
Yu R; Yang B; Chi X; Cai L; Liu C; Yang L; Wang X; He P; Lu X
Drug Des Devel Ther; 2017; 11():851-864. PubMed ID: 28360510
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of cytokine-induced killer cell infusion as an adjuvant therapy for postoperative hepatocellular carcinoma patients.
Pan K; Li YQ; Wang W; Xu L; Zhang YJ; Zheng HX; Zhao JJ; Qiu HJ; Weng DS; Li JJ; Wang QJ; Huang LX; He J; Chen SP; Ke ML; Wu PH; Chen MS; Li SP; Xia JC; Zeng YX
Ann Surg Oncol; 2013 Dec; 20(13):4305-11. PubMed ID: 23892527
[TBL] [Abstract][Full Text] [Related]
6. Serum alpha-fetoprotein measurement in predicting clinical outcome related to autologous cytokine-induced killer cells in patients with hepatocellular carcinoma undergone minimally invasive therapy.
Pan CC; Huang ZL; Li W; Zhao M; Zhou QM; Xia JC; Wu PH
Chin J Cancer; 2010 Jun; 29(6):596-602. PubMed ID: 20507732
[TBL] [Abstract][Full Text] [Related]
7. Autologous transplantation of cytokine-induced killer cells as an adjuvant therapy for hepatocellular carcinoma in Asia: an update meta-analysis and systematic review.
Cai XR; Li X; Lin JX; Wang TT; Dong M; Chen ZH; Jia CC; Hong YF; Lin Q; Wu XY
Oncotarget; 2017 May; 8(19):31318-31328. PubMed ID: 28412743
[TBL] [Abstract][Full Text] [Related]
8. A randomized, controlled trial of postoperative adjuvant cytokine-induced killer cells immunotherapy after radical resection of hepatocellular carcinoma.
Hui D; Qiang L; Jian W; Ti Z; Da-Lu K
Dig Liver Dis; 2009 Jan; 41(1):36-41. PubMed ID: 18818130
[TBL] [Abstract][Full Text] [Related]
9. A nomogram for predicting the benefit of adjuvant cytokine-induced killer cell immunotherapy in patients with hepatocellular carcinoma.
Pan QZ; Wang QJ; Dan JQ; Pan K; Li YQ; Zhang YJ; Zhao JJ; Weng DS; Tang Y; Huang LX; He J; Chen SP; Ke ML; Chen MS; Wicha MS; Chang AE; Zeng YX; Li Q; Xia JC
Sci Rep; 2015 Mar; 5():9202. PubMed ID: 25776856
[TBL] [Abstract][Full Text] [Related]
10. CIK cell cytotoxicity is a predictive biomarker for CIK cell immunotherapy in postoperative patients with hepatocellular carcinoma.
Pan QZ; Liu Q; Zhou YQ; Zhao JJ; Wang QJ; Li YQ; Tang Y; Gu JM; He J; Chen SP; Weng DS; Xia JC
Cancer Immunol Immunother; 2020 May; 69(5):825-834. PubMed ID: 32060687
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant Cytokine-Induced Killer Cell Therapy Improves Disease-Free and Overall Survival in Solitary and Nonmicrovascular Invasive Hepatocellular Carcinoma After Curative Resection.
Chen JL; Lao XM; Lin XJ; Xu L; Cui BK; Wang J; Lin GH; Shuang ZY; Mao YZ; Huang X; Yun JP; Jin JT; Li SP
Medicine (Baltimore); 2016 Feb; 95(5):e2665. PubMed ID: 26844496
[TBL] [Abstract][Full Text] [Related]
12. Intraperitoneal perfusion of cytokine-induced killer cells with local hyperthermia for advanced hepatocellular carcinoma.
Wang XP; Xu M; Gao HF; Zhao JF; Xu KC
World J Gastroenterol; 2013 May; 19(19):2956-62. PubMed ID: 23704829
[TBL] [Abstract][Full Text] [Related]
13. Cytokine-induced killer cells in combination with transcatheter arterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma patients.
Huang ZM; Li W; Li S; Gao F; Zhou QM; Wu FM; He N; Pan CC; Xia JC; Wu PH; Zhao M
J Immunother; 2013 Jun; 36(5):287-93. PubMed ID: 23719239
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant cytokine-induced killer cells with minimally invasive therapies augmented therapeutic efficacy of unresectable hepatocellular carcinoma.
Huang ZM; Lai CX; Zuo MX; An C; Wang XC; Huang JH; Ning E
J Cancer Res Ther; 2020; 16(7):1603-1610. PubMed ID: 33565506
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy with dendritic cells and cytokine-induced killer cells for hepatocellular carcinoma: A meta-analysis.
Cao J; Kong FH; Liu X; Wang XB
World J Gastroenterol; 2019 Jul; 25(27):3649-3663. PubMed ID: 31367163
[TBL] [Abstract][Full Text] [Related]
16. Cytokine-induced killer cell infusion combined with conventional treatments produced better prognosis for hepatocellular carcinoma patients with barcelona clinic liver cancer B or earlier stage: A systematic review and meta-analysis.
Li YC; Zhao L; Wu JP; Qu CX; Song QK; Wang RB
Cytotherapy; 2016 Dec; 18(12):1525-1531. PubMed ID: 27746013
[TBL] [Abstract][Full Text] [Related]
17. A randomized phase II study of autologous cytokine-induced killer cells in treatment of hepatocellular carcinoma.
Yu X; Zhao H; Liu L; Cao S; Ren B; Zhang N; An X; Yu J; Li H; Ren X
J Clin Immunol; 2014 Feb; 34(2):194-203. PubMed ID: 24337625
[TBL] [Abstract][Full Text] [Related]
18. TACE combined with dendritic cells and cytokine-induced killer cells in the treatment of hepatocellular carcinoma: A meta-analysis.
He G; Zheng C; Huo H; Zhang H; Zhu Z; Li J; Zhang H
Int Immunopharmacol; 2016 Nov; 40():436-442. PubMed ID: 27716591
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of transcatheter arterial chemoembolization combined with cytokine-induced killer cell therapy on hepatocellular carcinoma: a comparative study.
Hao MZ; Lin HL; Chen Q; Ye YB; Chen QZ; Chen MS
Chin J Cancer; 2010 Feb; 29(2):172-7. PubMed ID: 20109346
[TBL] [Abstract][Full Text] [Related]
20. High number of PD-1 positive intratumoural lymphocytes predicts survival benefit of cytokine-induced killer cells for hepatocellular carcinoma patients.
Chang B; Shen L; Wang K; Jin J; Huang T; Chen Q; Li W; Wu P
Liver Int; 2018 Aug; 38(8):1449-1458. PubMed ID: 29356308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
